Tag: Monoclonal antibody

spot_img
MEDICINE

Hympavzi (marstacimab): New Treatment for Hemophilia

SCIEU Team -
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...
MEDICINE

Lecanemab for Early Alzheimer’s Disease approved in the UK but refused in EU 

Umesh Prasad -
Monoclonal antibodies (mAbs) lecanemab and donanemab have been approved for the treatment of early Alzheimer’s disease in the UK and USA respectively while lecanemab...
COVID-19

‘‘A living WHO guideline on drugs for COVID-19’’: The Eighth version (Seventh update) Released

SCIEU Team -
The eighth version (seventh update) of a living guideline is released. It replaces earlier versions. The latest update includes a strong recommendation for the...
COVID-19

Sotrovimab Approval in the UK: A Monoclonal Antibody Effective Against Omicron, may work for Future Variants as well

SCIEU Team -
Sotrovimab, a monoclonal antibody already approved for mild to moderate COVID-19 in several countries gets approval by MHRA in the UK. This antibody was intelligently designed...
COVID-19

COVID-19: ‘Neutralising Antibody’ Trials Begins in the UK

Umesh Prasad -
University College London Hospitals (UCLH) has announced neutralising antibody trial against COVID-19. The announcement on 25 December 2020 says ‘’UCLH doses first patient in...
COVID-19

New Strains of SARS-CoV-2 (the virus responsible for COVID-19): Could ‘Neutralising Antibodies’ Approach be Answer to Rapid Mutation?

Umesh Prasad -
Several new strains of the virus have emerged since the pandemic began. New variants were reported as early as February 2020. The current variant...
COVID-19

Monoclonal Antibodies and Protein Based Drugs Could be Used to Treat COVID-19 Patients

Rajeev Soni -
Existing biologics such as Canakinumab (monoclonal antibody), Anakinra (monoclonal antibody) and Rilonacept (fusion protein) can be exploited as therapeutics that restrain inflammation in COVID-19...
MEDICINE

New Hope for Attacking the Deadliest Form of Malaria

SCIEU Team -
Researchers have isolated CIS43, a human antibody that can effectively prevent the deadliest malaria caused by the parasite Plasmodium falciparum. Malaria is one of...

Stay in touch:

87,845FansLike
45,152FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

ENGINEERING & TECHNOLOGY

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

0
The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...
MEDICINE

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

0
Cancer cells have electrically charged parts hence are influenced...
SPONSORED CONTENT

Scientific European invites Co-founder

0
Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...
PHYSICS

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

0
The quest for the answers to the open questions (such as, which...
BIOLOGY

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

0
In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...